URGENT-1: Bowel Urgency in Inflammatory Bowel Disease

Sponsor
Paris IBD Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06069167
Collaborator
(none)
1,000
12

Study Details

Study Description

Brief Summary

Bowel urgency is commonly defined as the sudden need to rush to the bathroom to empty one's bowel. In the field of inflammatory bowel disease (IBD) (including Crohn's disease (CD) and ulcerative colitis (UC)), bowel urgency is part of the top five research priorities for future IBD nursing research, and it is a symptom that patients consider to be most important when prioritizing their disease control. Urgency is a patient-reported outcome associated with compromised quality of life and future risk of hospitalizations, corticosteroids, and colectomy in patients with UC.

Caron et al. summarized data from 321 studies evaluating bowel urgency (Caron B et al. Clin Gastroenterol Hepatol. 2023). Only one third of these clinical studies clearly defined bowel urgency. Definition of bowel urgency was heterogeneous as 14 different definitions were identified. In most of these studies, non-validated questionnaires were used. They are based on subjective responses of the patients, and they could determine evaluation bias. These data emphasize the lack of standardization in bowel urgency assessment.

Condition or Disease Intervention/Treatment Phase
  • Other: Collection of data related to bowel urgency

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Bowel Urgency in Inflammatory Bowel Disease
Anticipated Study Start Date :
Oct 15, 2023
Anticipated Primary Completion Date :
Jun 15, 2024
Anticipated Study Completion Date :
Oct 15, 2024

Outcome Measures

Primary Outcome Measures

  1. To estimate the prevalence of bowel urgency in a cohort of patients with inflammatory bowel disease [Through study completion, an average of 12 months]

    Inability to defer defecation for more than 15 minutes in patients with inflammatory bowel disease

Secondary Outcome Measures

  1. To estimate the prevalence of bowel urgency in a cohort of Crohn's disease patients [Through study completion, an average of 12 months]

    Inability to defer defecation for more than 15 minutes in patients with Crohn's disease

  2. To estimate the prevalence of bowel urgency in a cohort of ulcerative colitis patients [Through study completion, an average of 12 months]

    Inability to defer defecation for more than 15 minutes in patients with ulcerative colitis

  3. To develop the URGENT index (i.e. inflammatory bowel disease-specific bowel urgency index) [Through study completion, an average of 12 months]

    Components of the index based on variables describing in systematic review Caron B et al. Clin Gastroenterol Hepatol. 2023 and IBD expert opinion

  4. To identify IBD-related risk factors associated with an increased risk of bowel urgency [Through study completion, an average of 12 months]

    Inability to defer defecation for more than 15 minutes and potentially predictive factors (i.e. baseline characteristics)

  5. To evaluate correlation between the URGENT index and the Urgency Numeric Rating Scale [Through study completion, an average of 12 months]

    Relationships between changes in the URGENT index and changes in the Urgency Numeric Rating Scale

  6. To evaluate correlation between the URGENT index and a Global Visual Evaluation [Through study completion, an average of 12 months]

    Relationship between changes in the URGENT index and changes in the Global Visual Evaluation on a 10-point visual analog scale ranging from 0 (minimal activity) to 10 (maximal activity)

  7. To determine the most appropriate definition of bowel urgency for patients with IBD [Through study completion, an average of 12 months]

    Urgent desire to defecate and/or extreme desire to defecate and/or immediate need to defecate and/or inability to defer defecation for more than 2 minutes and/or inability to defer defecation for more than 5 minutes and/or inability to defer defecation for more than 20 minutes and/or inability to defer defecation for more than 30 minutes and/or having to rush to the toilet and/or not making it to a toilet in time and/or having to stop whatever to have a bowel movement and/or difficult to withstand urge to open bowels and/or running to the bathroom and/or inability to delay bowel movements

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female, aged at least 18 years old

  • Diagnosis of inflammatory bowel disease according to the European Crohn´s and Colitis Organisation criteria for at least 3 months

  • Person who has received full information about the organization of the research and who has not objected to his or her participation and to the use of his or her data

  • Person affiliated to or beneficiary of a social security plan

Exclusion Criteria:
  • Person unable to comply with study procedures

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Paris IBD Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Paris IBD Center
ClinicalTrials.gov Identifier:
NCT06069167
Other Study ID Numbers:
  • PIBDC-2023-01
First Posted:
Oct 5, 2023
Last Update Posted:
Oct 5, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2023